Neuphoria Therapeutics
NEUP
#9921
Rank
โ‚น1.48 B
Marketcap
โ‚น438.93
Share price
0.38%
Change (1 day)
-55.32%
Change (1 year)

Revenue for Neuphoria Therapeutics (NEUP)

Revenue in 2024 (TTM): โ‚น56.85 Million

According to Neuphoria Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚น56.6 Million. a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Neuphoria Therapeutics from 2001 to 2024

Annual revenue

Year Revenue Change
2024 N/A
2023 N/A-100%
2022โ‚น15.48 M
2021N/A-100%
2020โ‚น1.88 M-98.83%
2019โ‚น0.16 B-7.86%
2018โ‚น0.17 B-35.7%
2017โ‚น0.27 B-18.5%
2016โ‚น0.33 B-0.15%
2015โ‚น0.33 B-77.01%
2014โ‚น1.44 B1142.79%
2013โ‚น0.11 B15.69%
2012โ‚น0.10 B-67.55%
2011โ‚น0.31 B69.97%
2010โ‚น0.18 B-8.89%
2009โ‚น0.20 B127.61%
2008โ‚น88.14 M75.83%
2007โ‚น50.13 M63.24%
2006โ‚น30.71 M109.1%
2005โ‚น14.68 M
2004N/A-100%
2003โ‚น39.51 M-9.15%
2002โ‚น43.5 M66.15%
2001โ‚น26.18 M